Holen Sie sich die Stockscreener-App
21.26
1.19%
0.25
Schlusskurs vom Vortag:
$21.01
Offen:
$21.04
24-Stunden-Volumen:
1.08M
Relative Volume:
0.74
Marktkapitalisierung:
$2.72B
Einnahmen:
$2.89B
Nettoeinkommen (Verlust:
$-33.80M
KGV:
-78.74
EPS:
-0.27
Netto-Cashflow:
$204.10M
1W Leistung:
-4.75%
1M Leistung:
-2.07%
6M Leistung:
+4.63%
1J Leistung:
-30.86%
1-Tages-Spanne:
$20.65
$21.27
1-Wochen-Bereich:
$20.65
$22.88
52-Wochen-Spanne:
$18.87
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Vergleichen Sie SGRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
21.26 | 2.69B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
334.32 | 82.15B | 72.70B | 5.97B | 7.29B | 23.79 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.43 | 15.70B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
153.02 | 13.78B | 20.52B | 1.46B | 1.41B | 15.12 |
|
DVA
Davita Inc
|
145.17 | 10.94B | 12.82B | 936.34M | 1.47B | 10.74 |
|
EHC
Encompass Health Corp
|
107.67 | 10.80B | 5.51B | 494.70M | 386.40M | 4.84 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Why is Surgery Partners Inc. stock attracting strong analyst attentionFastest-growing stock picks - jammulinksnews.com
How Surgery Partners Inc. stock performs during market volatilityStrategic High Profit Opportunities - Metal.it
Surgery Partners Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
Is Surgery Partners Inc. a good long term investmentUnstoppable trading performance - Autocar Professional
Does Surgery Partners Inc. stock pay reliable dividendsDynamic portfolio growth - jammulinksnews.com
What analysts say about Surgery Partners Inc. stockUnprecedented profits - Autocar Professional
What drives Surgery Partners Inc. stock priceOutperformance with explosive growth - jammulinksnews.com
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Re - GuruFocus
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details - The Manila Times
Surgery Partners Sets Q2 Earnings Date: Key Financial Updates Coming August 5 - Stock Titan
Surgery Partners Stock Rises on Positive Analyst OutlookNews and Statistics - IndexBox
Why Surgery Partners (SGRY) Stock Is Trading Up Today - TradingView
Why Surgery Partners (SGRY) Stock Is Trading Up Today | Markets | American Financial Group, Inc. - FinancialContent
Surgery Partners stock rises as CMS proposes favorable ASC rule changes - Investing.com Canada
Surgery Partners, Inc. (SGRY): A Bull Case Theory - Insider Monkey
1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of - Yahoo Finance
Surgery Partners stock rating reiterated by Cantor Fitzgerald at Overweight - Investing.com
(SGRY) Technical Data - news.stocktradersdaily.com
U.S. Ambulatory Surgery Center Market Growth in Future Scope - openPR.com
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Surgery Partners stock holds Buy rating at UBS on rejected Bain offer - Investing.com Canada
Surgery Partners stock hits 52-week low at 19.49 USD By Investing.com - Investing.com Nigeria
Surgery Partners: The Plunge Doesn't Justify An Upgrade (NASDAQ:SGRY) - Seeking Alpha
Ascension Buying AmSurg in Response to Outpatient Trend - Healthcare Innovation
U.S. Ambulatory Surgery Center Market Generated - openPR.com
UBS reiterates buy rating on Surgery Partners stock amid takeover rejection - Investing.com
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures By Investing.com - Investing.com UK
Surgery Partners ends acquisition talks with Bain Capital By Investing.com - Investing.com India
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures - Investing.com
Surgery Partners rejects Bain Capital's takeover proposal - MSN
Surgery Partners Rejects $3.3B Bain Offer - USA Herald
Surgery Partners Ends Buyout Talks with Bain Capital, Shares Slide - GuruFocus
Surgery Partners Rejects $3.3B Bain Offer, Eyes Public Growth - Law360
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surgery Partners Inc-Aktie (SGRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Burkhalter Danielle | Chief Human Resources Officer |
Mar 14 '25 |
Sale |
23.78 |
74 |
1,760 |
44,839 |
| Webb William Trenton | American Group President |
Mar 14 '25 |
Sale |
23.70 |
138 |
3,271 |
74,521 |
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):